CN
  • Hospital Line Marketing Department
  • Suzhou Huajian Hospital Line 1
  • Weizhenbio Hospital Line II
  • Beijing Kuike Liver Disease Line
  • Weizhenbio POCT Line
  • About Weizhenbio

    Weizhenbio Biotechnology Co., Ltd. (referred to as Weizhenbio) is a first-level subsidiary of Jiangsu Microdiag, and its marketing center is also one of the marketing centers of Microdiag. The marketing center is mainly responsible for the nationwide hospital market sales of cytokine diagnostic products such as DoptaTM DR-70, Mac-s POCT instrument and supporting reagents SAA, PCT, and interleukin series.

    Existing Products
  • Multispectrum™ DR-70 Kit

    Internationally recognized and exclusive domestic new pan-cancer early detection index, with a sensitivity of >74%, covering 13 common human tumors (lung, stomach, breast, colorectum, esophagus, liver, ovary, cervix, thyroid, bladder, head and neck, prostate)

  • POCT

    Mac-S fully automatic chemiluminescence immunoassay analyzer
    PCT, SAA, IL-6, IL-10 (registration in progress) - an important indicator for clinical infection, especially sepsis detection.

  • Hotline: 0512-8187-9848

    Address: Building 16, Northwest District, Suzhou Nano City, No. 99, Jinji Lake Avenue, Suzhou Industrial Park, Jiangsu Province